AGENDA
| Organizers: |
Kenrad Nelson, M.D.; Rajen Koshy, Ph.D.; Robert H. Purcell, M.D.; Jay H. Hoofnagle, M.D.; and
Averell H. Sherker, M.D., FRCP(C) |
|
| |
|
| 7:30 – 8:30 a.m. |
Registration |
| |
|
| 8:30 – 8:40 a.m. |
Welcome and Aims
Jay H. Hoofnagle, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| |
|
Session 1:
Moderators: |
The Hepatitis E Virus (HEV)
Rajen Koshy, Ph.D., National Institute of Allergy and Infectious Diseases (NIAID)
Robert H. Purcell, M.D., NIAID |
|
| |
|
| 8:40 – 9:00 a.m. |
Molecular Virology of HEV
Sue Emerson, Ph.D., NIAID |
| |
|
| 9:00 – 9:20 a.m. |
Diagnostic Assays for HEV
Harry Dalton, MBBS, DPhil, Royal Cornwall Hospital Trust and Peninsula College of Medicine and Dentistry (United Kingdom) |
| |
|
| 9:20 – 9:40 a.m. |
HEV as a Zoonosis
Xiang-Jin Meng, M.D., Ph.D., Virginia Polytechnic Institute and State University |
| |
|
| 9:40 – 10:10 a.m. |
Discussion
Moderators and Speakers |
| |
|
| 10:10 – 10:30 a.m. |
Break |
| |
|
Session 2:
Moderators: |
Epidemiology of Hepatitis E
Jay H. Hoofnagle, M.D., NIDDK
Harry Dalton, MBBS, DPhil, Royal Cornwall Hospital Trust and Peninsula College of Medicine and Dentistry |
|
| |
|
| 10:30 – 10:50 a.m. |
Epidemiology in Asia
Alain Labrique, Ph.D., M.H.S., Johns Hopkins University |
| |
|
| 10:50 – 11:10 a.m. |
Epidemiology in Europe
Philippe Colson, M.D., Centre Hospitalo-Universitaire Timone (France) |
| |
|
| 11:10 – 11:30 a.m. |
Epidemiology in the United States
Kenrad Nelson, M.D., Johns Hopkins University |
| |
|
| 11:30 – 11:50 a.m. |
Hepatitis E in the United States
Scott Holmberg, M.D., Centers for Disease Control and Prevention (CDC) |
| |
|
| 11:50 a.m. – 12:20 p.m. |
Discussion
Moderators and Speakers |
| |
|
| 12:20 – 1:30 p.m. |
Lunch and Posters |
| |
|
Session 3:
Moderators: |
Special Populations
Kenrad Nelson, M.D., Johns Hopkins University
Averell H. Sherker, M.D., FRCP(C), NIDDK |
|
| |
|
| 1:30 – 1:50 p.m. |
Clinical Course and Complications
Jay H. Hoofnagle, M.D., NIDDK |
| |
|
| 1:50 – 2:10 p.m. |
HEV and Acute Liver Failure
Robert Fontana, M.D., University of Michigan |
| |
|
| 2:10 – 2:30 p.m. |
HEV After Organ Transplantation
Norah Terrault, M.D., M.P.H., University of California, San Francisco |
| |
|
| 2:30 – 2:50 p.m. |
HEV and HIV Co-infection
Caryn Morse, M.D., M.P.H., Warren G. Magnuson Clinical Center (CC), National Institutes of Health (NIH) |
| |
|
| 2:50 – 3:20 p.m. |
Discussion
Moderators and Speakers |
| |
|
| 3:20 – 3:40 p.m. |
Break |
| |
|
Session 4:
Moderators: |
Treatment and Prevention
Sally Hojvat, U.S. Food and Drug Administration (FDA)
John Ward, M.D., CDC |
|
| |
|
| 3:40 – 4:00 p.m. |
HEV Screening in Blood Donors
Chenyu Xu, Ph.D., CC, NIH |
| |
|
| 4:00 – 4:20 p.m. |
HEV and Food Safety Issues
Julie Ann Kase, Ph.D., FDA |
| |
|
| 4:20 – 4:40 p.m. |
HEV Vaccines
James Wai Kuo Shih, Ph.D., Xiamen University (China) |
| |
|
| 4:40 – 5:00 p.m. |
Treatment of HEV
Nassim Kamar, M.D., Center Hospitalier Universitaire Rangueil (France) |
| |
|
| 5:00 – 5:30 p.m. |
Discussion of Future Needs
Moderators and Speakers |
| |
|
| 5:30 p.m. |
Adjournment |
| |
|
|
|
